Nuclear Medicine
CLINICAL DECISION SUPPORT
| Clinical Evaluation |
|---|
| Brain metabolism |
| Type of Imaging |
| PET |
| Grade of Recommendation |
| B (generally recommended) |
| Level of Evidence |
| well-established clinical and Nuclear Medicine recommendations |
| Effective Dose |
| 19 µSv/MBq |
| Bibliographic Reference |
|
Nobili F, Arbizu J, Bouwman F, Drzezga A, Agosta F, Nestor P, Walker Z, Boccardi M; EANM-EAN Task Force for the Prescription of FDG-PET for Dementi... read moreNobili F, Arbizu J, Bouwman F, Drzezga A, Agosta F, Nestor P, Walker Z, Boccardi M; EANM-EAN Task Force for the Prescription of FDG-PET for Dementing Neurodegenerative Disorders. European Association of Nuclear Medicine and European Academy of Neurology recommendations for the use of brain 18 F-fluorodeoxyglucose positron emission tomography in neurodegenerative cognitive impairment and dementia: Delphi consensus. Eur J Neurol. 2018; https://doi.org/10.1111/ene.13728 read less |
| Guide to Nuclear Medicine |
| Read the corresponding chapter |